Literature DB >> 25574104

Latent structure of irritable bowel syndrome symptom severity.

Fabian Jasper1, Boris Egloff1, Andrea Roalfe1, Michael Witthöft1.   

Abstract

AIM: To investigate the latent structure of an irritable bowel syndrome (IBS) symptom severity scale in a population of healthy adults.
METHODS: The Birmingham IBS symptom questionnaire which consists of three symptom specific scales (diarrhea, constipation, pain) was evaluated by means of structural equation modeling. We compared the original 3-factor solution to a general factor model and a bifactor solution in a large internet sample of college students (n = 875). Statistical comparisons of competing models were conducted by means of χ (2) difference tests. Regarding the evaluation of model fit, we examined the comparative fit index (CFI) and the Root Mean Square Error of Approximation (RMSEA).
RESULTS: Results clearly favored a bifactor model of IBS symptom severity (CFI = 0.99, RMSEA = 0.05) which consisted of a strong general IBS somatization factor and three symptom specific factors (diarrhea, constipation, pain) based on the subscales of the Birmingham IBS symptom questionnaire. The fit indices of the competing one factor model (CFI = 0.85, RMSEA = 0.17) and three factor model (CFI = 0.97, RMSEA = 0.08) were clearly inferior. χ (2) difference tests showed that the differences between the models were indeed significant in favor of the bifactor model (P < 0.001). Correlations of the four latent factors with measures of pain sensitivity, somatoform dissociation, fatigue severity, and demographic variables support the validity of our bifactor model of IBS specific symptom severity.
CONCLUSION: The findings suggest that IBS symptom severity might best be understood as a continuous and multidimensional construct which can be reliably and validly assessed with the B-IBS.

Entities:  

Keywords:  Bifactor; Birmingham irritable bowel syndrome scale; Gastrointestinal; Irritable bowel syndrome; Rome-III criteria

Mesh:

Year:  2015        PMID: 25574104      PMCID: PMC4284348          DOI: 10.3748/wjg.v21.i1.292

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

Review 1.  Functional somatic syndromes: one or many?

Authors:  S Wessely; C Nimnuan; M Sharpe
Journal:  Lancet       Date:  1999-09-11       Impact factor: 79.321

2.  Somatoform syndromes and disorders in a representative population sample of adolescents and young adults: prevalence, comorbidity and impairments.

Authors:  R Lieb; H Pfister; M Mastaler; H U Wittchen
Journal:  Acta Psychiatr Scand       Date:  2000-03       Impact factor: 6.392

3.  Prevalence, overlap, and predictors of functional somatic syndromes in a student sample.

Authors:  Susanne Fischer; Jens Gaab; Ulrike Ehlert; Urs M Nater
Journal:  Int J Behav Med       Date:  2013-06

4.  Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study.

Authors:  Michael Camilleri; Dominique Dubois; Bernard Coulie; Michael Jones; Peter J Kahrilas; Anne M Rentz; Amnon Sonnenberg; Vincenzo Stanghellini; Walter F Stewart; Jan Tack; Nicholas J Talley; William Whitehead; Dennis A Revicki
Journal:  Clin Gastroenterol Hepatol       Date:  2005-06       Impact factor: 11.382

5.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress.

Authors:  C Y Francis; J Morris; P J Whorwell
Journal:  Aliment Pharmacol Ther       Date:  1997-04       Impact factor: 8.171

6.  Irritable bowel syndrome: novel views on the epidemiology and potential risk factors.

Authors:  E Rey; N J Talley
Journal:  Dig Liver Dis       Date:  2009-08-08       Impact factor: 4.088

Review 7.  A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.

Authors:  J-R Malagelada
Journal:  Int J Clin Pract       Date:  2006-01       Impact factor: 2.503

Review 8.  Costs of irritable bowel syndrome in the UK and US.

Authors:  Stefanie Maxion-Bergemann; Frank Thielecke; Florian Abel; Rito Bergemann
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

9.  Gastrointestinal symptoms are still common in a general Western population.

Authors:  L A S van Kerkhoven; T Eikendal; R J F Laheij; M G H van Oijen; J B M J Jansen
Journal:  Neth J Med       Date:  2008-01       Impact factor: 1.422

10.  Quality of life of patients with irritable bowel syndrome in Korea.

Authors:  Jae Myung Park; Myung-Gyu Choi; Yong Sung Kim; Chang Hwan Choi; Suck Chei Choi; Su Jin Hong; Jeong Jo Jeong; Dong Ho Lee; Joon Seong Lee; Kwang Jae Lee; Hee Jung Son; In Kyung Sung
Journal:  Qual Life Res       Date:  2009-02-27       Impact factor: 4.147

View more
  1 in total

1.  Impact of symptom severity in patients with diarrhoea-predominant irritable bowel syndrome (IBS-D): results from two separate surveys of HCPs and patients with IBS-D.

Authors:  Anton Emmanuel; Richard William Goosey; Gwen Wiseman; Stephen Baker; Hans Törnblom
Journal:  BMC Gastroenterol       Date:  2020-04-26       Impact factor: 3.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.